Role of peroxisome proliferator-activated receptor β/δ and B-cell lymphoma-6 in regulation of genes involved in metastasis and migration in pancreatic cancer cells

PPAR Research

Volumn , Issue , 2013, Pages

  Coleman, Jeffrey D ^a   Thompson, Jerry T ^a   Smith III, Russell W ^a   Prokopczyk, Bogdan ^b,c   Vanden Heuvel, John P ^a,c,d  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c PENN STATE CANCER INSTITUTE   (United States)

^d INDIGO Biosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BETA DELTA; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BASEMENT MEMBRANE; CANCER CELL; CELL INVASION; EMBRYO; GENE CONTROL; HUMAN; HUMAN CELL; METASTASIS; MIGRATION; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 84878316872     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2013/121956     Document Type: Article

References (70)

1. Maitra A., Hruban R. H., Pancreatic cancer. Annual Review of Pathology: Mechanisms of Disease 2008 3 157 188 2-s2.0-41749100127 10.1146/annurev. pathmechdis.3.121806.154305 (Pubitemid 351488279)
2. Lowenfels A. B., Maisonneuve P., Epidemiology and risk factors for pancreatic cancer. Best Practice and Research: Clinical Gastroenterology 2006 20 2 197 209 2-s2.0-33645038661 10.1016/j.bpg.2005.10.001
3. Michaud D. S., Liu S., Giovannucci E., Willett W. C., Colditz G. A., Fuchs C. S., Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. Journal of the National Cancer Institute 2002 94 17 1293 1300 2-s2.0-0037019733
4. Michaud D. S., Vrieling A., Jiao L., Mendelsohn J. B., Steplowski E., Lynch S. M., Wactawski-Wende J., Arslan A. A., Bas Bueno-De-Mesquita H., Fuchs C. S., Gross M., Helzlsouer K., Jacobs E. J., Lacroix A., Petersen G., Zheng W., Allen N., Ammundadottir L., Bergmann M. M., Boffetta P., Buring J. E., Canzian F., Chanock S. J., Clavel-Chapelon F., Clipp S., Freiberg M. S., Michael Gaziano J., Giovannucci E. L., Hankinson S., Hartge P., Hoover R. N., Allan Hubbell F., Hunter D. J., Hutchinson A., Jacobs K., Kooperberg C., Kraft P., Manjer J., Navarro C., Peeters P. H. M., Shu X. O., Stevens V., Thomas G., Tjønneland A., Tobias G. S., Trichopoulos D., Tumino R., Vineis P., Virtamo J., Wallace R., Wolpin B. M., Yu K., Zeleniuch-Jacquotte A., Stolzenberg-Solomon R. Z., Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes and Control 2010 21 8 1213 1225 2-s2.0-77955708474 10.1007/s10552-010-9548-z
5. Everhart J., Wright D., Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. Journal of the American Medical Association 1995 273 20 1605 1609 2-s2.0-0029017953 10.1001/jama.273.20.1605
6. Raimondi S., Maisonneuve P., Lowenfels A. B., Epidemiology of pancreatic cancer: an overview. Nature Reviews Gastroenterology and Hepatology 2009 6 12 699 708 2-s2.0-74949144690 10.1038/nrgastro.2009.177
7. Adrian T. E., Inhibition of pancreatic cancer cell growth. Cellular and Molecular Life Sciences 2007 64 19-20 2512 2521 2-s2.0-35648940269 10.1007/s00018-007-7072-4 (Pubitemid 350035602)
8. Goldstein D., Carroll S., Apte M., Keogh G., Modern management of pancreatic carcinoma. Internal Medicine Journal 2004 34 8 475 481 2-s2.0-4444223823 10.1111/j.1444-0903.2004.00658.x (Pubitemid 39208275)
9. Chawta A., Repa J. J., Evans R. M., Mangelsdorf D. J., Nuclear receptors and lipid physiology: opening the x-files. Science 2001 294 5548 1866 1870 2-s2.0-0035976638 10.1126/science.294.5548.1866 (Pubitemid 33101573)
10. Lemberger T., Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annual Review of Cell and Developmental Biology 1996 12 335 363 2-s2.0-0029731662 10.1146/annurev.cellbio.12.1.335 (Pubitemid 26422717)
11. Fredenrich A., Grimaldi P. A., PPAR delta: an uncompletely known nuclear receptor. Diabetes and Metabolism 2005 31 1 23 27 2-s2.0-14744267131 (Pubitemid 40327589)
12. Cimini A., Cerù M. P., Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation. Stem Cell Reviews 2008 4 4 293 303 2-s2.0-58149401447 10.1007/s12015-008-9024-2
13. Michalik L., Desvergne B., Wahli W., Peroxisome proliferator-activated receptors β / δ: emerging roles for a previously neglected third family member. Current Opinion in Lipidology 2003 14 2 129 135 2-s2.0-0037396839 10.1097/00041433-200304000-00003 (Pubitemid 36521182)
14. Bishop-Bailey D., Bystrom J., Emerging roles of peroxisome proliferator-activated receptor- β / δ in inflammation. Pharmacology and Therapeutics 2009 124 2 141 150 2-s2.0-70349111436 10.1016/j.pharmthera. 2009.06.011
15. Lee C. H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M., Transcriptional repression of atherogenic inflammation: modulation by PPAR δ Science 2003 302 5644 453 457 2-s2.0-0142116239 10.1126/science.1087344 (Pubitemid 37296272)
16. Kharroubi I., Lee C. H., Hekerman P., Darville M. I., Evans R. M., Eizirik D. L., Cnop M., BCL-6: a possible missing link for anti-inflammatory PPAR- δ signalling in pancreatic beta cells. Diabetologia 2006 49 10 2350 2358 2-s2.0-33748489928 10.1007/s00125-006-0366-5 (Pubitemid 44359096)
17. Higashiyama H., Billin A. N., Okamoto Y., Kinoshita M., Asano S., Expression profiling of Peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray. Histochemistry and Cell Biology 2007 127 5 485 494 2-s2.0-34247403417 10.1007/s00418-007-0279-5 (Pubitemid 46632448)
18. Pandol S., Edderkaoui M., Gukovsky I., Lugea A., Gukovskaya A., Desmoplasia of pancreatic ductal adenocarcinoma. Clinical Gastroenterology and Hepatology 2009 7 11 S44 S47 2-s2.0-71849112654 10.1016/j.cgh.2009.07.039
19. Halbersztadt A., Haloń A., Pajak J., Robaczyński J., Rabczynski J., St Gabryś M., The role of matrix metalloproteinases in tumor invasion and metastasis. Ginekologia Polska 2006 77 1 63 71 2-s2.0-33749019492
20. Deryugina E. I., Quigley J. P., Matrix metalloproteinases and tumor metastasis. Cancer and Metastasis Reviews 2006 25 1 9 34 2-s2.0-33646576169 10.1007/s10555-006-7886-9 (Pubitemid 43723979)
21. Bloomston M., Zervos E. E., Rosemurgy A. S., Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Annals of Surgical Oncology 2002 9 7 668 674 2-s2.0-0036334059 10.1245/aso.2002.9.7.668 (Pubitemid 34857984)
22. Roomi M. W., Monterrey J. C., Kalinovsky T., Rath M., Niedzwiecki A., Patterns of MMP-2 and MMP-9 expression in human cancer cell lines. Oncology Reports 2009 21 5 1323 1333 2-s2.0-67649336792 10.3892/or-00000358
23. Kim H. J., Kim M. Y., Hwang J. S., Kim H. J., Lee J. H., Chang K. C., Kim J. H., Han C. W., Kim J. H., Seo H. G., PPAR δ inhibits IL-1 β -stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra. Cellular and Molecular Life Sciences 2010 67 12 2119 2130 2-s2.0-77953024399 10.1007/s00018-010-0328-4
24. Nakajima A., Tomimoto A., Fujita K., Sugiyama M., Takahashi H., Ikeda I., Hosono K., Endo H., Yoneda K., Iida H., Inamori M., Kubota K., Saito S., Nakajima N., Wada K., Nagashima Y., Nakagama H., Inhibition of peroxisome proliferator-activated receptor γ activity suppresses pancreatic cancer cell motility. Cancer Science 2008 99 10 1892 1900 2-s2.0-54949147269 10.1111/j.1349-7006.2008.00904.x
25. Farrow B., Evers B. M., Activation of PPAR γ increases PTEN expression in pancreatic cancer cells. Biochemical and Biophysical Research Communications 2003 301 1 50 53 2-s2.0-0037473753 10.1016/S0006-291X(02)02983-2 (Pubitemid 36268846)
26. Hashimoto K., Farrow B. J., Evers B. M., Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. Pancreas 2004 28 2 153 159 2-s2.0-1442304433 10.1097/00006676- 200403000-00006 (Pubitemid 38269775)
27. He T. C., Chan T. A., Vogelstein B., Kinzler K. W., PPAR δ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999 99 3 335 345 2-s2.0-0033615352 10.1016/S0092-8674(00)81664-5 (Pubitemid 29519912)
28. Park B. H., Vogelstein B., Kinzler K. W., Genetic disruption of PPAR δ decreases the tumorigenicity of human colon cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2598 2603 2-s2.0-0035956850 10.1073/pnas.051630998 (Pubitemid 32209528)
29. Bastie C., PPAR δ and PPAR γ: roles in fatty acids signalling, implication in tumorigenesis. Bulletin du Cancer 2002 89 1 23 28 2-s2.0-0036175039 (Pubitemid 34151312)
30. Glinghammar B., Skogsberg J., Hamsten A., Ehrenborg E., PPAR δ activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 2003 308 2 361 368 2-s2.0-0042388005 10.1016/S0006-291X(03)01384- 6 (Pubitemid 36937188)
31. Romanowska M., Al Yacoub N., Seidel H., Donandt S., Gerken H., Phillip S., Haritonova N., Artuc M., Schweiger S., Sterry W., Foerster J., PPAR δ enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. Journal of Investigative Dermatology 2008 128 1 110 124 2-s2.0-37049018807 10.1038/sj.jid.5700943 (Pubitemid 350249370)
32. Burdick A. D., Bility M. T., Girroir E. E., Billin A. N., Willson T. M., Gonzalez F. J., Peters J. M., Ligand activation of peroxisome proliferator-activated receptor- β / δ (PPAR β / δ) inhibits cell growth of human N/TERT-1 keratinocytes. Cellular Signalling 2007 19 6 1163 1171 2-s2.0-34147146967 10.1016/j.cellsig.2006.12.007 (Pubitemid 46561554)
33. Hollingshead H. E., Killins R. L., Borland M. G., Girroir E. E., Billin A. N., Willson T. M., Sharma A. K., Amin S., Gonzalez F. J., Peters J. M., Peroxisome proliferator-activated receptor- β / δ (PPAR β / δ) ligands do not potentiate growth of human cancer cell lines. Carcinogenesis 2007 28 12 2641 2649 2-s2.0-36949036752 10.1093/carcin/bgm183 (Pubitemid 350238968)
34. Kilian M., Gregor J. I., Heukamp I., Hanel M., Ahlgrimm M., Schimke I., Kristiansen G., Ommer A., Walz M. K., Jacobi C. A., Wenger F. A., Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer. Prostaglandins Leukotrienes and Essential Fatty Acids 2006 75 6 429 434 2-s2.0-33750458019 10.1016/j.plefa.2006.08.004 (Pubitemid 44649358)
35. Tian M., Cui Y. Z., Song G. H., Zong M. J., Zhou X. Y., Chen Y., Han J. X., Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008 8, article 241 2-s2.0-51349092847 10.1186/1471-2407-8-241
36. Fan Y., Wang Y., Tang Z., Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 315 321 (Pubitemid 351161205)
37. Stephen R. L., Gustafsson M. C. U., Jarvis M., Tatoud R., Marshall B. R., Knight D., Ehrenborg E., Harris A. L., Wolf C. R., Palmer C. N. A., Activation of peroxisome proliferator-activated receptor δ stimulates the proliferation of human breast and prostate cancer cell lines. Cancer Research 2004 64 9 3162 3170 2-s2.0-2342640982 10.1158/0008-5472.CAN-03-2760 (Pubitemid 38581418)
38. Kawa S., Nikaido T., Unno H., Usuda N., Nakayama K., Kiyosawa K., Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR γ ligand troglitazone. Pancreas 2002 24 1 1 7 2-s2.0-0036135985 10.1097/00006676-200201000-00001 (Pubitemid 34019653)
39. Eibl G., The role of PPAR- γ and its interaction with COX-2 in pancreatic cancer. PPAR Research 2008 2008 6 2-s2.0-47349128912 10.1155/2008/326915 326915 (Pubitemid 352000624)
40. Mackenzie G. G., Rasheed S., Wertheim W., Rigas B., NO-donating NSAIDs, PPAR δ and cancer: does PPAR δ contribute to colon carcinogenesis? PPAR Research 2008 2008 11 2-s2.0-45249096055 10.1155/2008/919572 919572 (Pubitemid 351842213)
41. Marin H. E., Peraza M. A., Billin A. N., Willson T. M., Ward J. M., Kennett M. J., Gonzalez F. J., Peters J. M., Ligand activation of peroxisome proliferator-activated receptor β inhibits colon carcinogenesis. Cancer Research 2006 66 8 4394 4401 2-s2.0-33646269042 10.1158/0008-5472.CAN-05-4277
42. Kim D. J., Bility M. T., Billin A. N., Willson T. M., Gonzalez F. J., Peters J. M., PPAR β / δ selectively induces differentiation and inhibits cell proliferation. Cell Death and Differentiation 2006 13 1 53 60 2-s2.0-33645004402 10.1038/sj.cdd.4401713
43. Kim D. J., Sandeep Prabhu K., Gonzalez F. J., Peters J. M., Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor- β / δ (PPAR β / δ). Carcinogenesis 2006 27 5 1105 1112 2-s2.0-33646181467 10.1093/carcin/bgi346
44. Yang X., Staren E. D., Howard J. M., Iwamura T., Bartsch J. E., Appert H. E., Invasiveness and MMP expression pancreatic carcinoma. Journal of Surgical Research 2001 98 1 33 39 2-s2.0-0035371329 10.1006/jsre.2001.6150 (Pubitemid 32493624)
45. Maatta M., Soini Y., Liakka A., Autio-Harmainen H., Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clinical Cancer Research 2000 6 7 2726 2734 2-s2.0-0033910993 (Pubitemid 30482111)
46. Evans J. D., Ghaneh P., Kawesha A., Neoptolemos J. P., Role of matrix metalloproteinases and their inhibitors in pancreatic cancer. Digestion 1997 58 6 520 528 2-s2.0-0030656475 (Pubitemid 27515714)
47. Lee C. S., Montebello J., Georgiou T., Rode J., Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. International Journal of Experimental Pathology 1994 75 2 79 83 2-s2.0-0028363866 (Pubitemid 24199768)
48. Senior R. M., Griffin G. L., Fliszar C. J., Shapiro S. D., Goldberg G. I., Welgus H. G., Human 92- and 72-kilodalton type IV collagenases are elastases. Journal of Biological Chemistry 1991 266 12 7870 7875 2-s2.0-0025874373 (Pubitemid 21906446)
49. Guo K., Ma Q., Wang L., Hu H., Li J., Zhang D., Zhang M., Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncology Reports 2009 22 4 825 830 2-s2.0-70350418226 10.3892/or-00000505
50. Takayama O., Yamamoto H., Damdinsuren B., Sugita Y., Ngan C. Y., Xu X., Tsujino T., Takemasa I., Ikeda M., Sekimoto M., Matsuura N., Monden M., Expression of PPAR δ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology. British Journal of Cancer 2006 95 7 889 895 2-s2.0-33749316388 10.1038/sj.bjc.6603343 (Pubitemid 44498105)
51. Tan N. S., Michalik L., Di-Poï N., Ng C. Y., Mermod N., Roberts A. B., Desvergne B., Wahli W., Essential role of Smad3 in the inhibition of inflammation-induced PPAR β / δ expression. The EMBO Journal 2004 23 21 4211 4221 2-s2.0-9144251051 10.1038/sj.emboj.7600437 (Pubitemid 39546159)
52. Glauser D. A., Schlegel W., The FoxO/Bcl-6/cyclin D2 pathway mediates metabolic and growth factor stimulation of proliferation in Min6 pancreatic β -cells. Journal of Receptors and Signal Transduction 2009 29 6 293 298 2-s2.0-71049185095 10.3109/10799890903241824
53. Toney L. M., Cattoretti G., Graf J. A., Merghoub T., Pandolfi P. P., Dalla-Favera R., Ye B. H., Dent A. L., BCL-6 regulates chemokine gene transcription in macrophages. Nature Immunology 2000 1 3 214 220 2-s2.0-0034278508
54. Wlodarska I., Nooyen P., Maes B., Martin-Subero J. I., Siebert R., Pauwels P., De Wolf-Peeters C., Hagemeijer A., Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 2003 101 2 706 710 2-s2.0-0037438585 10.1182/blood-2002-05-1592 (Pubitemid 36077597)
55. Tibiletti M. G., Martin V., Bernasconi B., Del Curto B., Pecciarini L., Uccella S., Pruneri G., Ponzoni M., Mazzucchelli L., Martinelli G., Ferreri A. J., Pinotti G., Assanelli A., Scandurra M., Doglioni C., Zucca E., Capella C., Bertoni F., BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome. Human Pathology 2009 40 5 645 652 2-s2.0-64049093008 10.1016/j.humpath.2008.06.032
56. Tzankov A., Schneider A., Hoeller S., Dirnhofer S., Prognostic importance of BCL6 rearrangements in diffuse large B-cell lymphoma with respect to Bcl6 protein levels and primary lymphoma site. Human Pathology 2009 40 7 1055 1056 2-s2.0-66549127133 10.1016/j.humpath.2009.03.008
57. Shvarts A., Brummelkamp T. R., Scheeren F., Koh E., Daley G. Q., Spits H., Bernards R., A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling. Genes and Development 2002 16 6 681 686 2-s2.0-0037087737 10.1101/gad.929302 (Pubitemid 34274037)
58. Holzmann K., Kohlhammer H., Schwaenen C., Wessendorf S., Kestler H. A., Schwoerer A., Rau B., Radlwimmer B., Döhner H., Lichter P., Gress T., Bentz M., Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes. Cancer Research 2004 64 13 4428 4433 2-s2.0-3042743983 10.1158/0008-5472.CAN-04-0431 (Pubitemid 38856913)
59. Perez-Rosado A., Artiga M. J., Vargiu P., Sanchez-Aguilera A., Alvarez-Barrientos A., Piris M. A., BCL6 represses NF B activity in diffuse large B-cell lymphomas. Journal of Pathology 2008 214 4 498 507 2-s2.0-40349091558 10.1002/path.2279 (Pubitemid 351340570)
60. Takada M., Hirata K., Ajiki T., Suzuki Y., Kuroda Y., Expression of Receptor for Advanced Glycation End products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepato-Gastroenterology 2004 51 58 928 930 2-s2.0-3042513726 (Pubitemid 38822439)
61. Tempia-Caliera A. A., Horvath L. Z., Zimmermann A., Tihanyi T. T., Korc M., Friess H., Büchler M. W., Adhesion molecules in human pancreatic cancer. Journal of Surgical Oncology 2002 79 2 93 100 2-s2.0-0036154774 10.1002/jso.10053 (Pubitemid 34111934)
62. Friess H., Berberat P., Schilling M., Kunz J., Korc M., Büchler M. W., Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. Journal of Molecular Medicine 1996 74 1 35 42 2-s2.0-0030024411 (Pubitemid 26034370)
63. Wu C. Y., Hsieh H. L., Sun C. C., Yang C. M., IL-1 β induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-Jun cascade in rat brain astrocytes. GLIA 2009 57 16 1775 1789 2-s2.0-71249161927 10.1002/glia.20890
64. Gordon G. M., Ledee D. R., Feuer W. J., Fini M. E., Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cellsy. Journal of Cellular Physiology 2009 221 2 402 411 2-s2.0-70149120995 10.1002/jcp.21869
65. Li L., Xing F. Q., Chen S. L., Role of interleukin-1beta in regulating human cultured endometrial cell MMP-9 and TIMP-3 expressions in the mid-secretory phase. Nan Fang Yi Ke Da Xue Xue Bao 2006 26 8 1143 1145 2-s2.0-42949102618
66. Greco E., Basso D., Fogar P., Mazza S., Navaglia F., Zambon C. F., Falda A., Pedrazzoli S., Ancona E., Plebani M., Pancreatic cancer cells invasiveness is mainly affected by interleukin-1 β not by transforming growth factor- β 1. International Journal of Biological Markers 2005 20 4 235 241 2-s2.0-30844470670 (Pubitemid 43103619)
67. Takaya H., Andoh A., Shimada M., Hata K., Fujiyama Y., Bamba T., The expression of chemokine genes correlates with nuclear factor- B activation in human pancreatic cancer cell lines. Pancreas 2000 21 1 32 40 2-s2.0-0033945484 10.1097/00006676-200007000-00049 (Pubitemid 30421932)
68. Solinas G., Marchesi F., Garlanda C., Mantovani A., Allavena P., Inflammation-mediated promotion of invasion and metastasis. Cancer and Metastasis Reviews 2010 29 2 243 248 2-s2.0-77954565039 10.1007/s10555-010-9227- 2
69. Vaday G. G., Schor H., Rahat M. A., Lahat N., Lider O., Transforming growth factor- β suppresses tumor necrosis factor α -induced matrix metalloproteinase-9 expression in monocytes. Journal of Leukocyte Biology 2001 69 4 613 621 2-s2.0-0035071646 (Pubitemid 32294847)
70. Kim H. J., Ham S. A., Kim S. U., Hwang J. Y., Kim J. H., Chang K. C., Yabe-Nishimura C., Kim J. H., Seo H. G., Transforming growth factor- β 1 is a molecular target for the peroxisome proliferator-activated receptor δ Circulation Research 2008 102 2 193 200 2-s2.0-41149134486 10.1161/CIRCRESAHA. 107.158477 (Pubitemid 351651123)